Scrip News - US panel backs paediatric use of Seroquel and Zyprexa, but splits on Geodon

Scrip Clinica RAJ Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

Supplements & Reports

Scrip

US panel backs paediatric use of Seroquel and Zyprexa, but splits on Geodon
11 June 2009
Sue Sutter

The US FDA's outside experts say that two atypical antipsychotics – AstraZeneca's Seroquel (quetiapine fumarate) and Lilly's Zyprexa (olanzapine) – are safe and effective for paediatric use in bipolar mania and schizophrenia.

However, the psychopharmacologic drugs...

Please Login to read the full article.

Not a subscriber? Request a FREE Trial Subscribe to Scrip

RELATED CONTENT

NEWS Scrip News

Other Informa News

ANALYSIS Scrip Analysis

Other Informa Analysis

COMMENT Scrip Comment

Changing the way we think about mental disorders

FEATURES Scrip Features

Face-to-face: Evotec CEO tells of turnaround

Other Informa Features

SCIENCE

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

EVENTS

Congress on G Protein-Coupled Receptors in Drug Discovery

17 March 2010

Berlin, Germany

Drug Discovery Targets and Tools

17 March 2010

Berlin, Germany

Conference on Intellectual Property in the Pharmaceutical Industry

22 March 2010

London, UK

JOB OF THE WEEK Promote your vacancy here

DIRECTORY Scrip Directory 2009

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Clinical Research

Animal Pharm